Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparison of synthesized and acquired high b-value diffusion-weighted MRI for detection of prostate cancer

Cancer Imaging(2024)10.1186/s40644-024-00723-6Source: DataRank Database

Comparison of synthesized and acquired high b-value diffusion-weighted MRI for detection of prostate cancer is a research paper published in Cancer Imaging (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 1.29)OA: goldTopics (87)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Christopher C. Conlin ORCID,Allison Y. Zhong ORCID,Troy S. Hussain,Aritrick Chatterjee ORCID,Gregory S. Karczmar ORCID

Live enrichment

PubMed:38972972 PMC:PMC11229343 OpenAlex:https://openalex.org/W4400431597

Foundation for the National Institutes of Health

Grant: NIH/NIBIB K08EB026503

Foundation for the National Institutes of Health

Grant: NIH UL1TR000100

NCATS NIH HHS

Grant: UL1 TR000100

National Institutes of Health

Grant: 5K08EB026503-04

Improving assessment of prostate cancer bone metastases using advanced diffusion imaging

National Institutes of Health

Grant: 3UL1TR000100-05S2

San Diego Clinical and Translational Research Institute

American Society for Radiation Oncology

Prostate Cancer Foundation

FWCI

1.29

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://cancerimagingjournal.biomedcentral.com/counter/pdf/10.1186/s40644-024-00723-6

GOLDhttps://cancerimagingjournal.biomedcentral.com/counter/pdf/10.1186/s40644-024-00723-6

publisherhttps://cancerimagingjournal.biomedcentral.com/counter/pdf/10.1186/s40644-024-00723-6

publisherhttps://link.springer.com/content/pdf/10.1186/s40644-024-00723-6.pdf

publisherhttps://link.springer.com/article/10.1186/s40644-024-00723-6/fulltext.html

Fields of Study

MRI in cancer diagnosisProstate Cancer Diagnosis and TreatmentAdvanced Neuroimaging Techniques and ApplicationsMedicineEngineering0302 clinical medicine03 medical and health sciencesHumansMaleProstatic NeoplasmsDiffusion Magnetic Resonance ImagingAgedRetrospective StudiesMiddle AgedAged, 80 and overProstate

MeSH Terms

AgedAged, 80 and overHumansMaleMiddle AgedProstateProstatic NeoplasmsRetrospective StudiesDiffusion Magnetic Resonance Imaging

Keywords

MedicineProstate cancerNuclear medicineProstateConfidence intervalReceiver operating characteristicDiffusion MRIProstate biopsyEffective diffusion coefficientRadiologyMagnetic resonance imagingCancerInternal medicineDiffusion-weighted ImagingRestricted Spectrum ImagingSynthetic High B-valuesPrevention (rcdc)MaleAgingR895-920Prostate Cancer (rcdc)Aging (rcdc)Clinical Research (rcdc)Biomedical Imaging (rcdc)Medical physics. Medical radiology. Nuclear medicine80 and over80 and over (mesh)32 Biomedical and Clinical Sciences (for-2020)Male (mesh)RC254-282Cancer (rcdc)Aged, 80 and overHumans (mesh)Neoplasms. Tumors. Oncology. Including cancer and carcinogens1112 Oncology and Carcinogenesis (for)Middle AgedNuclear Medicine & Medical Imaging (science-metrix)Nuclear Medicine & Medical ImagingBiomedical ImagingProstatic Neoplasms (mesh)Research ArticleUrologic DiseasesDiffusion Magnetic Resonance Imaging (mesh)Retrospective Studies (mesh)Clinical SciencesOncology and Carcinogenesis610Clinical ResearchMiddle Aged (mesh)3211 Oncology and carcinogenesis (for-2020)Humans3202 Clinical Sciences (for-2020)AgedRetrospective StudiesBiomedical and Clinical SciencesAged (mesh)PreventionProstatic NeoplasmsCancer (hrcs-hc)Prostate (mesh)Diffusion Magnetic Resonance ImagingUrologic Diseases (rcdc)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Peace, Justice and strong institutions

Related Papers (5)

Difference in Diffusion-Weighted Magnetic Resonance Imaging and Diffusion Tensor Imaging Parameters Between Endometrioid Endometrial Adenocarcinoma and Uterine Serous Adenocarcinoma

International Journal of Gynecological Cancer(2017)

OpenAlex related

10.1097/igc.0000000000001054

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy

Prostate International(2016)

OpenAlex related

10.1016/j.prnil.2016.12.002

ANALYSIS OF FRACTIONAL ANISOTROPY (FA) VALUES AND APPARENT DIFFUSION COEFFICIENT (ADC) VALUES IN ISCHEMIC STROKE DISEASES OF MRI GE 3 TESLA

Journal Of Vocational Health Studies(2019)

OpenAlex related

10.20473/jvhs.v2.i3.2019.107-111

Incidental Prostate Infections: Developing the Prostate Microbiome

American Journal of Clinical Pathology(2020)

OpenAlex related

10.1093/ajcp/aqaa161.301

Detection of prostatic peripheral zone cancer based on quantitative analysis of 3.0T MR Diffusion Tensor Imaging

Proceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition(2023)

OpenAlex related

10.58530/2022/3738